This inventor holds 3 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: Ocumension Therapeutics (Suzhou) Co., Ltd., Chinese Academy of Sciences. Active years: 2019-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2019-2026
Title: Innovations of Inventor Liang Tan
Introduction
Liang Tan is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical synthesis, holding 3 patents that showcase his innovative approach to drug development. His work focuses on creating compounds that target specific diseases, demonstrating both efficacy and safety.
Latest Patents
One of Liang Tan's latest patents is for a compound described as a 1H-pyrazole derivative, which serves as a dual target inhibitor of Syk and VEGFR2. This compound is designed to inhibit spleen tyrosine kinase (Syk) and vascular endothelial growth factor receptor 2 (VEGFR2) in subjects, providing a method for treating allergic, autoimmune, and inflammatory diseases. The compound exhibits excellent dual inhibitory activity and targeting specificity, making it suitable for ocular administration due to its high eye-to-blood ratio.
Another significant patent involves a monocyclic β-lactam-siderophore conjugate, which is aimed at treating bacterial infectious diseases. This patent outlines a method for synthesizing the conjugate and its use in combating infections, showcasing Liang Tan's commitment to addressing critical health challenges through innovative solutions.
Career Highlights
Liang Tan has worked with esteemed organizations such as the Chinese Academy of Sciences and Ocumension Therapeutics (Suzhou) Co., Ltd. His experience in these institutions has allowed him to refine his skills in pharmaceutical research and development, contributing to his success as an inventor.
Collaborations
Throughout his career, Liang Tan has collaborated with talented individuals, including Yushe Yang and Qunhuan Kou. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries.
Conclusion
Liang Tan's contributions to pharmaceutical innovation are noteworthy, with his patents reflecting a deep understanding of complex biological systems. His work continues to pave the way for advancements in medical treatments, showcasing the importance of innovation in addressing health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile